Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022
November 03, 2022 08:30 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, sent the...
Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure
November 03, 2022 08:30 ET
|
Sight Sciences, Inc.
Worldwide, more than one million trabecular microbypass stents have been implanted in combination with cataract surgery.Despite glaucoma medications and prior microbypass stenting, target IOP may no...
Aramis Biosciences Completes Enrollment of its Phase II Clinical Trial Evaluating A197 for the Treatment of Dry Eye Disease
November 03, 2022 08:00 ET
|
Aramis Biosciences
BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, today announced the completion of enrollment in its Phase II...
Samsung Bioepis Wins ‘Company of the Year, Asia-Pacific’ Award at the Global Generics & Biosimilars Awards 2022
November 03, 2022 02:00 ET
|
Samsung Bioepis
Recognized and awarded for its leadership and expertise in biosimilars – following 2020 Biosimilar Initiative of the Year awardAlso shortlisted as finalists in Company of the Year, Regulatory...
Ocuphire Announces Peer-Reviewed Publication in BMC Ophthalmology for Nyxol® and Strategic Partnership with American Society of Ophthalmic Administrators (ASOA)
November 02, 2022 08:10 ET
|
Ocuphire Pharma
FARMINGTON HILLS, Mich., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing...
ACGME Recognizes 2023 Graduate Medical Education Community Awardees
November 01, 2022 13:09 ET
|
Accreditation Council for Graduate Medical Education
Chicago, IL, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The Accreditation Council for Graduate Medical Education (ACGME) is proud to announce its 2023 Award recipients, recognizing the strength, innovation,...
Surgical Microscopes Market Size to Surpass USD 1184.34 Million by 2030 at 10.94% CAGR – Report by Market Research Future (MRFR)
November 01, 2022 13:00 ET
|
Market Research Future
New York, USA, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Surgical Microscopes Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Surgical Microscopes Market...
Nextech Wins 2022 Public Relations and Marketing Excellence Award
November 01, 2022 10:44 ET
|
Nextech Systems, Inc.
TAMPA, Fla., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Today the Business Intelligence Group announced that Nextech won the 2022 Public Relations and Marketing Excellence Award for Marketing Department of...
Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022
October 27, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Vyluma Announces Positive Results From Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
October 27, 2022 12:00 ET
|
Vyluma, Inc.
BRIDGEWATER, N.J., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing multiple assets for the treatment of refractive errors, today announced top-line...